News & Insights

Candidate ID: How to go from hits to lead candidates

We tend to think of antibodies as being defined by their...

Like our research colleagues across the entire global scientific community, our team here at Antibody Solutions...

A strategic approach to peptide design yields success

When deciding which antigens to use for an antibody discovery...

If the last year has taught us anything, it’s that major biological threats can emerge seemingly out of nowhere,...

Here at Antibody Solutions, we believe that starting with the best possible input will yield the best possible output....

“Mystery is at the heart of creativity. That, and surprise.”  Julia Cameron

Hybridoma Cell Fusion 101 When it comes to...

Mutations Found in the South African and UK COVID-19 Virus Strains Improve the Stability of the ACE2-Spike RBD Complex

As we’ve noted in some recent blog posts (here and here, for instance), our team at Antibody Solutions is joining the...

Editor’s note: Welcome to 2021, and to our first in a year-long series of posts that will explore the essentials in...

Examining mutations in the SARS-CoV-2 Spike (S) Protein Receptor Binding Domain (RBD) at the ACE2 receptor S protein...

Antibody Solutions is doing its part to respond to the COVID-19 pandemic, including original research, tool discovery,...

Accessing the Untapped Potential of 33% of Human IgG

Harvard economist Michael Porter, PhD offers a clever observation...

In the science shot heard ‘round the world, Pfizer and BioNTech announced Monday that their vaccine candidate (aka...

Antibody Solutions is doing its part to respond to the COVID-19 pandemic, including original research, tool discovery,...

On July 30th, we had the pleasure of moderating a virtual panel on Antibody Discovery and the Pandemic for the San...